Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for AIDS.

T Sorg1, M Methali

  • 1Department of Gene Therapy, Transgene, Strasbourg, France.

Transfusion Science
|May 7, 1997
PubMed
Summary
This summary is machine-generated.

Somatic gene therapy offers potential for treating Acquired Immunodeficiency Syndrome (AIDS) by modifying hematopoietic stem cells to resist Human Immunodeficiency Virus type 1 (HIV-1). This approach aims to repopulate the body with resistant cells, controlling viral spread and potentially preventing AIDS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic absorption of FD&C blue dye associated with patient mortality.

Postgraduate medical journal·2003
Same author

Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing.

Archives of orthopaedic and trauma surgery·2003
Same author

How can adenovirus-mediated catalase and superoxide dismutase gene transfer improve the outcome of pancreatic cells for transplantation?

Transplantation proceedings·2001
Same author

Mycobacterium szulgai osteomyelitis.

The Journal of infection·1998
Same author

[Gene therapy for hereditary and acquired human diseases].

Annales d'endocrinologie·1995
Same author

[Amalgam. Classification and evaluation].

Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia·1989
Same journal

Discontinuous automated calcium supplementation during thrombocytapheresis with the haemonetics MCS+ version C.

Transfusion science·2002
Same journal

Is Brazil entering a new age?

Transfusion science·2001
Same journal

Is Brazil entering a new age?

Transfusion science·2001
Same journal

Post-transfusion thrombocytopenia in recipients with anti-HLA antibody.

Transfusion science·2000
Same journal

The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values.

Transfusion science·2000
Same journal

A relationship between glucose metabolism and NO-mediated iron mobilization from cells.

Transfusion science·2000
See all related articles

Area of Science:

  • Gene Therapy
  • Immunology
  • Virology

Background:

  • Acquired Immunodeficiency Syndrome (AIDS) lacks effective treatments, making it a target for innovative therapies.
  • Human Immunodeficiency Virus type 1 (HIV-1) primarily infects hematopoietic cells, including stem cells and CD4+ T-cells.

Purpose of the Study:

  • To explore the potential of somatic gene therapy for treating HIV-1 infection and AIDS.
  • To investigate the use of genetically modified cells to confer resistance to HIV-1.
  • To examine immunological strategies for augmenting anti-HIV-1 immune responses.

Main Methods:

  • Introduction of foreign antiviral genes into hematopoietic stem cells or CD4+ cells.
  • Reimplantation of genetically modified cells into HIV-1 infected patients.

Related Experiment Videos

  • Development of strategies to enhance host cytotoxic T lymphocyte responses against HIV-1.

    • Main Results:

    • Theoretically, repopulation with genetically modified, HIV-1-resistant CD4+ cells could control viral propagation in vivo.
    • Augmenting host anti-HIV-1 cytotoxic T lymphocyte responses may prevent virus spread and the onset of AIDS.

    Conclusions:

    • Somatic gene therapy presents a promising avenue for AIDS treatment by creating HIV-1-resistant cells.
    • Immunological strategies to boost anti-HIV-1 T-cell responses are under development.
    • These experimental treatments require rigorous clinical evaluation to determine their therapeutic value.